IN8bio Statistics

Total Valuation

IN8bio has a market cap or net worth of $36.62 million. The enterprise value is $29.32 million.

Market Cap	36.62M
Enterprise Value	29.32M

Important Dates

The next estimated earnings date is Thursday, August 8, 2024, after market close.

Earnings Date	Aug 8, 2024
Ex-Dividend Date	n/a

Share Statistics

IN8bio has 44.12 million shares outstanding. The number of shares has increased by 75.02% in one year.

Shares Outstanding	44.12M
Shares Change (YoY)	+75.02%
Shares Change (QoQ)	+24.98%
Owned by Insiders (%)	22.86%
Owned by Institutions (%)	39.88%
Float	22.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.09
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.10, with a Debt / Equity ratio of 0.33.

Current Ratio	4.10
Quick Ratio	n/a
Debt / Equity	0.33
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -151.40% and return on invested capital (ROIC) is -133.93%.

Return on Equity (ROE)	-151.40%
Return on Assets (ROA)	-107.80%
Return on Capital (ROIC)	-133.93%
Revenue Per Employee	n/a
Profits Per Employee	-$1.00M
Employee Count	31
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -51.46% in the last 52 weeks. The beta is 0.06, so IN8bio's price volatility has been lower than the market average.

Beta (5Y)	0.06
52-Week Price Change	-51.46%
50-Day Moving Average	1.02
200-Day Moving Average	1.11
Relative Strength Index (RSI)	41.54
Average Volume (20 Days)	191,643

Short Selling Information

The latest short interest is 756,891, so 1.72% of the outstanding shares have been sold short.

Short Interest	756,891
Short Previous Month	389,665
Short % of Shares Out	1.72%
Short % of Float	3.39%
Short Ratio (days to cover)	0.94

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-31.13M
Pretax Income	-31.04M
Net Income	-31.04M
EBITDA	-28.50M
EBIT	-31.04M
Earnings Per Share (EPS)	-$0.91

Full Income Statement

Balance Sheet

The company has $13.02 million in cash and $5.72 million in debt, giving a net cash position of $7.30 million or $0.17 per share.

Cash & Cash Equivalents	13.02M
Total Debt	5.72M
Net Cash	7.30M
Net Cash Per Share	$0.17
Equity (Book Value)	17.53M
Book Value Per Share	0.40
Working Capital	11.91M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$23.82 million and capital expenditures -$242,000, giving a free cash flow of -$24.06 million.

Operating Cash Flow	-23.82M
Capital Expenditures	-242,000
Free Cash Flow	-24.06M
FCF Per Share	-$0.56

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

IN8bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-75.02%
Shareholder Yield	-75.02%
Earnings Yield	-84.77%
FCF Yield	-65.70%

Analyst Forecast

The average price target for IN8bio is $8.83, which is 963.86% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.83
Price Target Difference	963.86%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2